Tag Archives: Latest

Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD

The entire JAK inhibitor family of medicines is feeling the ripple effects from a safety signal flagged for Pfizer’s Xeljanz. Now, the first marketed drug in the class is encountering increased scrutiny from the FDA. The FDA has pushed back a decision for Incyte’s application for Jakafi in steroid-refractory chronic graft-versus-host disease (GVHD) by three months, the… Read More »

The Latest: Australia won’t buy J&J coronavirus vaccine

CANBERRA, Australia — The Australian government has decided against buying the single-dose Johnson & Johnson coronavirus vaccine as a way to accelerate its immunization program. Health Minister Greg Hunt said Tuesday the Johnson & Johnson vaccine is similar to the AstraZeneca product, which Australia already contracted to buy. Australia had planned to rely on Australian-manufactured… Read More »